We are live on ! Find out more
PG

Prostatis Group Portfolio holdings

AUM $429M
1-Year Est. Return 26.55%
This Fund
S&P 500
This Quarter Est. Return
-2.26%
1 Year Est. Return
+26.55%
3 Year Est. Return
+72.92%
5 Year Est. Return
+90.2%
10 Year Est. Return
AUM
$205M
AUM Growth
-$10.3M
Cap. Flow
-$145M
Cap. Flow %
-70.77%
Top 10 Hldgs %
53.46%
Holding
261
New
11
Increased
50
Reduced
48
Closed
149
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDV icon
26
iShares International Select Dividend ETF
IDV
$8.74B
$1.78M 0.87%
67,919
+9,939
+17% +$263K
SPHD icon
27
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.4B
$1.77M 0.86%
45,152
-17,414
-28% -$718K
XOM icon
28
ExxonMobil
XOM
$656B
$1.73M 0.84%
14,671
+1,222
+9% +$134K
HYG icon
29
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$1.63M 0.8%
22,174
-848
-4% -$63.3K
CVX icon
30
Chevron
CVX
$409B
$1.63M 0.8%
9,575
+2,270
+31% +$367K
BND icon
31
Vanguard Total Bond Market
BND
$160B
$1.57M 0.77%
22,548
-20,178
-47% -$1.44M
SPGP icon
32
Invesco S&P 500 GARP ETF
SPGP
$2.25B
$1.51M 0.74%
16,539
+4,986
+43% +$465K
TMO icon
33
Thermo Fisher Scientific
TMO
$227B
$1.43M 0.7%
2,829
+5
+0.2% +$2.66K
HD icon
34
Home Depot
HD
$320B
$1.41M 0.69%
4,622
-295
-6% -$94.9K
VWO icon
35
Vanguard FTSE Emerging Markets ETF
VWO
$128B
$1.35M 0.66%
34,371
-50,944
-60% -$2.08M
VV icon
36
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$1.34M 0.66%
6,869
-28
-0.4% -$5.7K
FPE icon
37
First Trust Preferred Securities and Income ETF
FPE
$6.28B
$1.25M 0.61%
75,941
+10,894
+17% +$175K
VCLT icon
38
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.72B
$1.24M 0.6%
17,283
+1,001
+6% +$75.4K
IVV icon
39
iShares Core S&P 500 ETF
IVV
$889B
$1.21M 0.59%
2,820
-3,346
-54% -$1.5M
RSPT icon
40
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.85B
$1.13M 0.55%
40,158
-1,032
-3% -$30.1K
IGLD icon
41
FT Vest Gold Strategy Target Income ETF
IGLD
$581M
$1.1M 0.54%
59,037
+10,464
+22% +$198K
NVDA icon
42
NVIDIA
NVDA
$5.56T
$1.01M 0.49%
23,140
-131,400
-85% -$5.89M
KO icon
43
Coca-Cola
KO
$379B
$975K 0.48%
17,253
+630
+4% +$37.8K
PG icon
44
Procter & Gamble
PG
$340B
$967K 0.47%
6,485
+768
+13% +$117K
NOC icon
45
Northrop Grumman
NOC
$73.2B
$954K 0.47%
2,168
+310
+17% +$136K
IBM icon
46
IBM
IBM
$221B
$934K 0.46%
6,736
+73
+1% +$10.4K
WMT icon
47
Walmart Inc
WMT
$850B
$924K 0.45%
17,067
+3,120
+22% +$166K
TJUL icon
48
Innovator Equity Defined Protection ETF - 2 Yr to July 2027
TJUL
$116M
$900K 0.44%
+36,477
New +$903K
VZ icon
49
Verizon
VZ
$208B
$869K 0.42%
26,747
+2,179
+9% +$73.6K
VTIP icon
50
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
$819K 0.4%
17,313
+398
+2% +$18.8K

Similar funds

Prostatis Group's Q3 2023 Portfolio in Review

As of Q3 2023, Prostatis Group held 261 positions worth $205M, down 4.8% from $215M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Prostatis Group withdrew a net $145M in Q3 2023, closing 149 positions and reducing 48 holdings. Its most notable exit was ARK Autonomous Technology & Robotics ETF, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 84% of assets, down from 85% a quarter earlier, followed by Technology and Industrials.

Against the trend, Prostatis Group opened a new position in State Street SPDR Bloomberg 1-3 Month T-Bill ETF worth $22.9M.

  • Prostatis Group's largest Q3 2023 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 249,300 shares worth $22.9M.
  • Prostatis Group added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q3 2023, an estimated $4.64M increase.
  • Prostatis Group's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $23.6M.
  • Prostatis Group fully exited ARK Autonomous Technology & Robotics ETF in Q3 2023, selling an estimated $10.3M.
  • Prostatis Group's ten largest holdings make up 53% of its $205M portfolio in Q3 2023.
  • Prostatis Group opened 11 new positions and closed 149 in Q3 2023.
  • Prostatis Group's portfolio value fell 4.8% quarter-over-quarter to $205M.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.